Jump to content

සැකිල්ල:Infobox drug/testcases8

විකිපීඩියා වෙතින්

|type= vaccine/combo/mab/blank සැකිල්ල:Drugbox/testcases/navbox

Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
all_all
all_all
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
blank
Pharmacokinetic data
Bioavailabilitybioavail
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
blank
Pharmacokinetic data
Bioavailabilitybioavail
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
blank w/IUPACname
Pharmacokinetic data
Bioavailabilitybioavail
Identifiers
  • iupac-name
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
blank w/IUPACname
Pharmacokinetic data
Bioavailabilitybioavail
Identifiers
  • iupac-name
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
විරේචනය mab = data10; source=data11, target=data12 (freetext)
mab, source
 | mab = Whole antibody
 | fab = [[Fab fragment]]
 | f(ab')2 = [[F(ab')2 fragment|F(ab')<sub>2</sub> fragment]]
 | fab' = [[Fab' fragment]]
 | scfv = [[Single-chain variable fragment]]
 | discfv = Di-[[single-chain variable fragment]]
 | sdab = [[Single domain antibody]]
 | 3funct = [[Trifunctional antibody]]
 | clfab = [[Chemically linked Fab]]
 | bite = [[Bi-specific T-cell engager]]
 | ?
if mab= then use source=
| label11 = [[Monoclonal antibody#Production|Source]]
|  data11 = {{#ifeq: {{{type|}}} | mab | {{#switch: {{lc:{{{source|}}}}}
 | =
 | a = [[Rat]]
 | e = [[Hamster]]
 | i = [[Primate]]
 | o = [[Mouse]]
 | u = [[Human]]
 | xi/a = [[chimeric antibody|Chimeric]] ([[rat]]/[[human]])
 | xi/e = [[chimeric antibody|Chimeric]] ([[hamster]]/[[human]])
 | xi/i = [[chimeric antibody|Chimeric]] ([[primate]]/[[human]])
 | xi/o = [[chimeric antibody|Chimeric]] ([[mouse]]/[[human]])
 | xi = [[chimeric antibody|Chimeric]]
 | zu/a = [[Humanized]] (from [[rat]])
 | zu/e = [[Humanized]] (from [[hamster]])
 | zu/i = [[Humanized]] (from [[primate]])
 | zu/o = [[Humanized]] (from [[mouse]])
 | zu = [[Humanized]]
 | xizu/a = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[rat]]/[[human]])
 | xizu/e = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[hamster]]/[[human]])
 | xizu/i = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[primate]]/[[human]])
 | xizu/o = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[mouse]]/[[human]])
 | xizu = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid
 | axo = [[Rat]]/[[mouse]] hybrid
 | {{{source|}}} [[:Category:Drugboxes with unformatted antibody source]]
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Monoclonal antibody
Type?
Clinical data
AHFS/Drugs.comMonograph
MedlinePlusa602026
Pharmacokinetic data
Bioavailabilityincreases when administered with food
Identifiers
CAS Number
NIAID ChemDB
Chemical and physical data
Formulachem_form
Molar mass877.031 g/mol
Melting point100 °C (212 °F)
Infobox drug/testcases8
Monoclonal antibody
Type?
Clinical data
AHFS/Drugs.comMonograph
MedlinePlusa602026
Pharmacokinetic data
Bioavailabilityincreases when administered with food
Identifiers
CAS Number
NIAID ChemDB
Chemical and physical data
Formulachem_form
Molar mass877.031 g/mol
Melting point100 °C (212 °F)
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
combo
Combination of
c1? Class
c2? Class
Pharmacokinetic data
Bioavailabilitybioavail
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
combo
Combination of
c1? Class
c2? Class
Pharmacokinetic data
Bioavailabilitybioavail
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)


Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
combo5
Combination of
c1cl1
c2c2
c4cl4
c5cl5
Pharmacokinetic data
Bioavailabilitybioavail
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
combo5
Combination of
c1cl1
c2c2
c4cl4
c5cl5
Pharmacokinetic data
Bioavailabilitybioavail
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)

|vaccin_type=

 |killed |inactivated = Killed/Inactivated
 |attenuated = [[Attenuated virus]]
 |live = Live bacteria
 |toxoid = [[Toxoid]]
 |subunit = Subunit
 |protein subunit |protein = [[Protein subunit]]
 |conjugate=[[Conjugate vaccine]]
 |recombinant = [[Recombinant DNA|Recombinant Vector]]
 |dna = [[DNA vaccination]]
 | ?
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
vaccine w/target
Vaccine description
Target_target_
Vaccine typeAttenuated
Pharmacokinetic data
Bioavailabilityincreases when administered with food
Identifiers
CAS Number
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
vaccine w/target
Vaccine description
Target_target_
Vaccine typeAttenuated
Pharmacokinetic data
Bioavailabilityincreases when administered with food
Identifiers
CAS Number
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
vaccine, no target
Vaccine description
Vaccine typeAttenuated
Pharmacokinetic data
Bioavailabilityincreases when administered with food
Identifiers
CAS Number
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)
vaccine, no target
Vaccine description
Vaccine typeAttenuated
Pharmacokinetic data
Bioavailabilityincreases when administered with food
Identifiers
CAS Number
Chemical and physical data
Formulachem_form
Melting point100 °C (212 °F)

TITLE tests (drug_name, INN)

[සංස්කරණය]

විරේචනය

Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
INN: Linezolid
Skeletal formula of linezolid
Clinical data
Pronunciation/njˈməʊniə/
Trade namesLinospan, Zyvox, Zyvoxam, Zyvoxid
Other namesLenzomore
AHFS/Drugs.comMonograph
MedlinePlusa602004
License data
Pregnancy
category
  • AU: C
Dependence
liability
High
Addiction
liability
Low
Routes of
administration
Intravenous infusion, oral
ATC code
Pharmacokinetic data
Bioavailability~100% (oral)
Protein bindingLow (31%)
MetabolismHepatic (50–70%, CYP not involved)
Metabolitessome stuff
Onset of action1 hr
Elimination half-life4.2–5.4 hours (shorter in children)
Duration of action1 to 3 hr
ExcretionNonrenal, renal, and fecal
Identifiers
  • (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
NIAID ChemDB
PDB ligand
Chemical and physical data
FormulaC16H20FN3O4
Molar mass337.346 g/mol
3D model (JSmol)
Density1.40 g/cm3
Melting point135 °C (275 °F)
Boiling point140 °C (284 °F) (decomposes)
Solubility in water3 mg/mL (20 °C)
  • O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3
  • InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 YesY
  • Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N YesY
 ☒NYesY (what is this?)  (verify)
Infobox drug/testcases8
INN: Linezolid
Skeletal formula of linezolid
Clinical data
Pronunciation/njˈməʊniə/
Trade namesLinospan, Zyvox, Zyvoxam, Zyvoxid
Other namesLenzomore
AHFS/Drugs.comMonograph
MedlinePlusa602004
License data
Pregnancy
category
  • AU: C
Dependence
liability
High
Addiction
liability
Low
Routes of
administration
Intravenous infusion, oral
ATC code
Pharmacokinetic data
Bioavailability~100% (oral)
Protein bindingLow (31%)
MetabolismHepatic (50–70%, CYP not involved)
Metabolitessome stuff
Onset of action1 hr
Elimination half-life4.2–5.4 hours (shorter in children)
Duration of action1 to 3 hr
ExcretionNonrenal, renal, and fecal
Identifiers
  • (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
NIAID ChemDB
PDB ligand
Chemical and physical data
FormulaC16H20FN3O4
Molar mass337.346 g/mol
3D model (JSmol)
Density1.40 g/cm3
Melting point135 °C (275 °F)
Boiling point140 °C (284 °F) (decomposes)
Solubility in water3 mg/mL (20 °C)
  • O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3
  • InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 YesY
  • Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N YesY
 ☒NYesY (what is this?)  (verify)

විරේචනය

English language variants: Licence or License

[සංස්කරණය]
See also WP:ENGVAR: english language variant of the article
In {{Infobox drug}}: spelling of licence/license. Default is to be en-US: License.
Use new parameter |engvar= for non-default spelling:
Default licenSe (US)
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
demo
Clinical data
License data
demo
Clinical data
License data
|engvar=en-US licenSe
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
demo
Clinical data
License data
demo
Clinical data
License data
|engvar=en-UK licenCe
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
demo
Clinical data
Licence data
demo
Clinical data
Licence data
|engvar=en-NZ licenCe
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
demo
Clinical data
Licence data
demo
Clinical data
Licence data

The infobox title is a logical result of input:

  • {{PAGENAME}} (default)
  • |drug_name= (overwrites, eg when PAGENAME is not the INN drugname)
  • |INN= (added, when PAGENAME/drug_name is not the INN name)
See ප්‍රවර්ගය:Infobox drug articles with non-default infobox title (1)

විරේචනය (reduced infobox)

Current infobox title: Diamorphine (INN)
The new situation required an edit.
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Heroin
INN: Diamorphine
Clinical data
Pronunciation/ˈhɛro:ɪn/
Other namesDiamorphine, Diacetylmorphine, Acetomorphine, (Dual) Acetylated morphine, Morphine diacetate
AHFS/Drugs.comheroin
Dependence
liability
Physical: Very high
Psychological: Very high
Addiction
liability
Very high
Routes of
administration
Inhalation, transmucosal, intravenous, oral, intranasal, rectal, intramuscular
ATC code
Legal status
Legal status
  • AU: S9 (Prohibited substance)
Identifiers
  • (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC21H23NO5
Molar mass369.41 g/mol
Heroin
INN: Diamorphine
Clinical data
Pronunciation/ˈhɛro:ɪn/
Other namesDiamorphine, Diacetylmorphine, Acetomorphine, (Dual) Acetylated morphine, Morphine diacetate
AHFS/Drugs.comheroin
Dependence
liability
Physical: Very high
Psychological: Very high
Addiction
liability
Very high
Routes of
administration
Inhalation, transmucosal, intravenous, oral, intranasal, rectal, intramuscular
ATC code
Legal status
Legal status
  • AU: S9 (Prohibited substance)
Identifiers
  • (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC21H23NO5
Molar mass369.41 g/mol

Lysergide (LSD)

[සංස්කරණය]

විරේචනය Reduced infobox.

Current infobox title: Lysergic acid diethylamide (pagename, not INN)
New situation would be (adding "(LSD)" is just a liberty I took, to help our readers):
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Lysergic acid diethylamide (LSD)
INN: Lysergide
Clinical data
Other namesAcid, LSD, lysergide
Dependence
liability
Low
Addiction
liability
None
Routes of
administration
Oral, etc
ATC code
  • none
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic
Elimination half-life3–5 hours
ExcretionRenal
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC20H25N3O
Molar mass323.44 g·mol−1
Lysergic acid diethylamide (LSD)
INN: Lysergide
Clinical data
Other namesAcid, LSD, lysergide
Dependence
liability
Low
Addiction
liability
None
Routes of
administration
Oral, etc
ATC code
  • none
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic
Elimination half-life3–5 hours
ExcretionRenal
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC20H25N3O
Molar mass323.44 g·mol−1
No need to use |INN=. Note the titletext (mousehover).
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
α-Methyltryptamine
Clinical data
Other namesIndopan; IT-290, IT-403, U-14,164E, 3-IT
Routes of
administration
Oral
ATC code
  • none
Identifiers
  • 2-(1H-indol-3-yl)-1-methyl-ethylamine
CAS Number
Chemical and physical data
FormulaC11H14N2
Molar mass174.25 g·mol−1
α-Methyltryptamine
Clinical data
Other namesIndopan; IT-290, IT-403, U-14,164E, 3-IT
Routes of
administration
Oral
ATC code
  • none
Identifiers
  • 2-(1H-indol-3-yl)-1-methyl-ethylamine
CAS Number
Chemical and physical data
FormulaC11H14N2
Molar mass174.25 g·mol−1
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Aspirin
Identifiers
CAS Number
Aspirin
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Aspirin MP
INN: inn
Identifiers
CAS Number
Aspirin MP
INN: inn
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Aspirin
Identifiers
CAS Number
Aspirin
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Infobox drug/testcases8
INN: inn
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Aspirin
INN: inn
Identifiers
CAS Number
Aspirin
INN: inn
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Aspirin
Identifiers
CAS Number
Aspirin
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
INN: Infobox drug/testcases8
Identifiers
CAS Number
Infobox drug/testcases8
INN: Infobox drug/testcases8
Identifiers
CAS Number
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases8
Infobox drug/testcases8
"https://si.wikipedia.org/w/index.php?title=සැකිල්ල:Infobox_drug/testcases8&oldid=682127" වෙතින් සම්ප්‍රවේශනය කෙරිණි